Close
CDMO Safety Testing 2026
Novotech

Schreiner MediPharm Develops Novel Cut-Through Indicator for Closure Seals

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic...

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...
- Advertisement -

Blauvelt, NY – Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, has introduced a cut-through indicator functionality for closure seals that makes tampering attempts clearly visible. The solutionโ€™s special design enables flexible integration of the security feature, offering an effective and cost-efficient solution for product protection, and helping to secure the broader pharmaceutical supply chain.

The new cut-through indicator function leaves any attempt at tampering readily and irreversibly apparent. This approach effectively prevents, for example, the frequently used method of tampering with folding boxes by cutting open the seal and reapplying it with transparent adhesive tape.

Schreiner MediPharmโ€™s cut-through indicator function is not designed as a standardized label, but rather as a modular feature that can be integrated individually into existing or newly developed closure seals. This means that the cut-through indicator function is customized to suit the respective seal and specific application. The single-layer structure enables flexible and cost-efficient adaptation to various materials and customer-specific designs. In addition, the function satisfies the highest security requirements for pharmaceutical packaging according to ISO 21976, and the European Falsified Medicines Directive 2011/62/EU.

Featuring thin, long, highly flexible strips, the solutionโ€™s particularly conspicuous die-cutting contours make lateral shifting or defects caused by tampering attempts plainly visible. Security features such as raised structures and irregular outer contours can also be integrated to further enhance the protective effect. Likewise, special graphic design options can be incorporated โ€“ for instance, guilloches as an added authentication feature.

Drugs that have been faked or tampered with pose considerable risks both to patient health and to the reputations of pharmaceutical companies. The new cut-through indicator function exemplifies Schreiner MediPharmโ€™s commitment to supporting the integrity of the pharmaceutical supply chain.

Schreiner MediPharm
Company Logo

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic...

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป